# Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers

> **NCT04330716** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 269 (actual)

## Conditions studied

- Breast Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Metastatic Prostate Cancer

## Interventions

- **BEHAVIORAL:** Standard Genetic Counseling
- **BEHAVIORAL:** Educational Video

## Key facts

- **NCT ID:** NCT04330716
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 269 (ACTUAL)
- **Last updated:** 2024-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04330716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04330716, "Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04330716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*